Position in AZN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$429,299
New position
Shares Held
2,264
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#904
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrive Wealth Management, LLC holds $13,579,206 across 8 Drug Manufacturers - General names. AZN ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,510 | $5,716,864 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,054 | $2,319,939 | |
| 3 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 4 | ABBV |
AbbVie Inc.
|
5,708 | $1,436,361 | |
| 5 | AMGN |
Amgen Inc
|
3,218 | $1,165,302 | |
| 6 | PFE |
Pfizer Inc
|
28,655 | $690,012 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,264 | $429,299 | |
| 8 | GSK |
GSK plc
|
6,031 | $316,145 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,299 | 2,264 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||